@article{49578ec83ed14080b612342af7764be1,
title = "Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration",
abstract = "Disturbance in lipid metabolism has been suggested as a major pathogenic factor for age-related macular degeneration (AMD). Conventional lipid measures have been inconsistently associated with AMD. Other factors that can alter lipid metabolism include lipoprotein phenotype and genetic mutations. We performed a case-control study to examine the association between lipoprotein profle and neovascular AMD (nAMD) and whether the cholesterylester transfer protein (CETP) D442G mutation modulates these associations. Patients with nAMD had signifcantly higher concentrations of HDL and IDL compared with controls. The increase in HDL particles in nAMD patients was driven by an excess of medium-sized particles. Concurrently, patients with nAMD also had lower Apo A-1, lower VLDL and chylomicron lipoprotein. Many of these associations showed a dose-dependent association between controls, early AMD cases, and nAMD cases. Adjustment for the presence of the D442G mutation at the CETP locus did not signifcantly alter the increased AMD risk associated with HDL particle concentration. AMD is associated with variation in many lipoprotein subclasses, including increased HDL and IDL particles and decreased Apo A-1, VLDL, and chylomicron particles. These data suggest widespread systemic disturbance in lipid metabolism in the pathogenesis of AMD, including possible alterations in lipoprotein carrier capacity.",
keywords = "Cholesterylester transfer protein, Genetics, High density lipoprotein",
author = "Cheung, {Chui Ming Gemmy} and Alfred Gan and Qiao Fan and Chee, {Miao Ling} and Apte, {Rajendra S.} and Khor, {Chiea Chuen} and Ian Yeo and Ranjana Mathur and Cheng, {Ching Yu} and Wong, {Tien Yin} and {Shyong Tai}, E.",
note = "Funding Information: This work was supported by National Medical Research Council Grants 1003/2009 and 0796/2003 and Biomedical Research Council Grants 10/1/35/19/671, 501/25-5, and SPF2014/002. R.S.A. was supported by National Institutes of Health Grant R01EY019287, a Research to Prevent Blindness Physician Scientist Award, an unrestricted grant from Research to Prevent Blindness to Washington University, the Starr Foundation, the Jeffrey Fort Innovation Fund, the Carl Marshall and Mildred Allen Reeves Foundation, and American Foundation for Aging Research Vision Core Grant P30EY02687. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The lead author affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Author{\textquoteright}s Choice—Final version free via Creative Commons CC-BY license. Manuscript received 11 December 2016 and in revised form 6 July 2017. Published, JLR Papers in Press, July 11, 2017 DOI https://doi.org/10.1194/jlr.M073684 Publisher Copyright: {\textcopyright} 2017 by the American Society for Biochemistry and Molecular Biology, Inc.",
year = "2017",
doi = "10.1194/jlr.M073684",
language = "English",
volume = "58",
pages = "1785--1796",
journal = "Journal of lipid research",
issn = "0022-2275",
number = "9",
}